Northwestern University spinout Grove Biopharma, a synthetic biology specialist developing a platform known as Bionic ...

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...

Lawyers for Todd Engel, 62, filed suit yesterday in New Jersey superior court. According to the complaint, Engel is now ...

Penpulimab has picked up a pair of approvals in nasopharyngeal carcinoma (NPC), becoming only the second drug to be cleared ...

As a psychiatric provider working with people from all walks of life, I’ve seen how serious mental health conditions, ...

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...

The 4th In Vivo Cell Engineering & Gene Editing Summit, taking place June 3–5, 2025 in Boston, is the definitive event ...

According to its backers, MAGIC-I is Ireland's first clinical study of its type in cancer care and will harness "the power of ...

The platform's library of specialised life sciences agents creates an adaptable framework that breaks down silos between data ...

Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...

There is currently no approved treatment for intracerebral haemorrhagic (ICH) stroke, but Belgian start-up Bioxodes hopes to ...

Despite being on the US market since 1989 – initially for medical uses like strabismus and blepharospasm, and later for ...